SI301: Human Recombinant Phospho-Ubiquitin (Ser65)

$350.00$410.00

Clear

Specifications

Ubiquitin is a small polypeptide that can be conjugated via its C-terminus to amine groups of lysine residue on target proteins. Additional ubiquitin moieties can be subsequently conjugated to this initial ubiquitin, utilizing any one (of seven) lysine residues on the surface of ubiquitin. Phosphorylation was preformed on mutant ubiquitin to facilitate a change on amino acid residue 20 from a serine to a cysteine. The primary function of ubiquitination is to mark proteins for degradation. More specifically, defective mitochondria are selectively degraded after being marked with ubiquitin through a mechanism involving PTEN-induced putative kinase 1 (PINK1) and Parkin. PINK1 is stabilized and accumulates in depolarized mitochondria, where it phosphorylates many proteins. Parkin itself is activated through PINK1-mediated phosphorylated at Ser65 as well as interacting with phosphorylated ubiquitin (also accomplished with PINK1 at Ser65).

Phospho-Ubiquitin (pS65) is enzymatically generated with PINK1 kinase from Red Flour Beetle (Tribolium castaneum).

Product Information

Purity ≥ 98% SDS-PAGE and Mass Spectrometry
Molecular Weight 8660 Da
Physical State Liquid
Quantity 100 µg or 200 µg
Solubility >30 mg/ml
Formulation PBS pH 7.4, 5mM TCEP
Storage -80°C, avoid freeze/thaw cycles

Additional information

SKU

,

Size

100µg, 200µg

Reviews

There are no reviews yet.

Be the first to review “SI301: Human Recombinant Phospho-Ubiquitin (Ser65)”

Application

  • Invitro experiments related to activation of Parkin and PINK1.
  • Biomarker discovery for Parkinson’s disease.
  • Invitro models for understanding role of pSer65UB in pathogenesis of PD.